- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Sr. Sales Executive-BC | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Nov 19, 2024 |
| Medical Science Liaison-Oncology-Breast Cancer | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Research & Development | Nov 14, 2024 |
| (Senior) Market Access Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Market Access | Nov 12, 2024 |
| (Sr.) Sales Executive-Solid Tumor | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Nov 04, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| Key Account Executive | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Oct 28, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Research & Development | Oct 09, 2024 |
| Associate Sales Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jul 18, 2024 |
| (Sr.) Sales Executive-OPH | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jun 12, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى